Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response

Cancer Research

Volumn 69, Issue 10, 2009, Pages 4235-4243

  Szokalska, Angelika ^a   Makowski, Marcin ^a   Nowis, Dominika ^a   Wilczyński, Grzegorz M ^a,b   Kujawa, Marek ^a   Wójcik, Cezary ^c   Młynarczuk Biały, Izabela ^a   Salwa, Pawel ^a   Bil, Jacek ^a   Janowska, Sylwia ^a   Agostinis, Patrizia ^d   Verfaillie, Tom ^d   Bugajski, Marek ^a   Gietka, Jan ^a   Issat, Tadeusz ^a   Głodkowska, Eliza ^a   Mrówka, Piotr ^a   Stoklosa, Tomasz ^a   Hamblin, Michael R ^e   Mróz, Paweł ^e   Jakóbisiak, Marek ^a   Golab, Jakub ^a   more..

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^c Indiana University School of Medicine Evansville   (United States)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; HYPERICIN; PHOTOFRIN; PROTEASOME INHIBITOR; VERTEPORFIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CARBONYLATION; CELLULAR STRESS RESPONSE; COLON ADENOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG INHIBITION; DRUG POTENTIATION; ENDOPLASMIC RETICULUM STRESS; EXPERIMENTAL MOUSE; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; UBIQUITINATION; UNFOLDED PROTEIN RESPONSE;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DIHEMATOPORPHYRIN ETHER; ENDOPLASMIC RETICULUM; HELA CELLS; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASMS; PHOTOCHEMOTHERAPY; PORPHYRINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN DENATURATION; REACTIVE OXYGEN SPECIES; SINGLET OXYGEN; UBIQUITIN;

EID: 66249133081     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3439     Document Type: Article

References (48)

1. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976;36:2326-2329
2. Juzenas P, Moan J. Singlet oxygen in photosensitization. J Environ Pathol Toxicol Oncol 2006;25:29-50. (Pubitemid 43341233)
3. Bachowski GJ, Pintar TJ, Girotti AW. Photosensitized lipid peroxidation and enzyme inactivation by membrane- bound merocyanine 540: reaction mechanisms in the absence and presence of ascorbate. Photochem Photobiol 1991;53:481-491
4. Girotti AW. Photosensitized oxidation of cholesterol in biological systems: reaction pathways, cytotoxic effects and defense mechanisms. J Photochem Photobiol B 1992;13:105-118
5. Davies MJ. Singlet oxygen-mediated damage to proteins and its consequences. Biochem Biophys Res Commun 2003;305:761-770 (Pubitemid 36579294)
6. Cadet J, Ravanat JL, Martinez GR, Medeiros MH, Di Mascio P. Singlet oxygen oxidation of isolated and cellular DNA: product formation and mechanistic insights. Photochem Photobiol 2006;82:1219-1225
7. Klotz LO, Kroncke KD, Sies H. Singlet oxygen-induced signaling effects in mammalian cells. Photochem Photobiol Sci 2003;2:88-94. (Pubitemid 41646723)
8. Nowis D, Golab J. Photodynamic therapy and oxidative stress. In: Hamblin MR, Mroz P, editors. Advances in photodynamic therapy: basic, translational, and clinical. Boston (MA); London: Artech House; 2008. p. 151-178
9. Wang HP, Hanlon JG, Rainbow AJ, Espiritu M, Singh G. Up-regulation of Hsp27 plays a role in the resistance of human colon carcinoma HT29 cells to photooxidative stress. Photochem Photobiol 2002;76:98-104.
10. Jalili A, Makowski M, Switaj T, et al. Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res 2004;10:4498-4508 (Pubitemid 38878894)
11. Xue LY, He J, Oleinick NL. Rapid tyrosine phosphorylation of HS1 in the response of mouse lymphoma L5178Y-R cells to photodynamic treatment sensitized by the phthalocyanine Pc 4. Photochem Photobiol 1997;66:105-113 (Pubitemid 127470640)
12. Korbelik M, Sun J, Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res 2005;65:1018-1026 (Pubitemid 40216464)
13. Mitra S, Goren EM, Frelinger JG, Foster TH. Activation of heat shock protein 70 promoter with meso-tetrahydroxyphenyl chlorin photodynamic therapy reported by green fluorescent protein in vitro and in vivo. Photochem Photobiol 2003;78:615-622
14. Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 2005;74:739-789 (Pubitemid 40995523)
15. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519-529 (Pubitemid 46985379)
16. Romisch K. Endoplasmic reticulum-associated degradation. Annu Rev Cell Dev Biol 2005;21:435-456 (Pubitemid 41740642)
17. Wojcik C, Di Napoli M. Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy. Stroke 2004;35:1506-1518 (Pubitemid 38697484)
18. Golab J, Bauer TM, Daniel V, Naujokat C. Role of the ubiquitin-proteasome pathway in the diagnosis of human diseases. Clin Chim Acta 2004;340:27-40. (Pubitemid 38167506)
19. Grune T, Merker K, Sandig G, Davies KJ. Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem Biophys Res Commun 2003;305:709-718 (Pubitemid 36579287)
20. Dunlop RA, Rodgers KJ, Dean RT. Recent developments in the intracellular degradation of oxidized proteins. Free Radic Biol Med 2002;33:894-906. (Pubitemid 35284029)
21. Grune T, Jung T, Merker K, Davies KJ. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and "aggresomes" during oxidative stress, aging, and disease. Int J Biochem Cell Biol 2004;36:2519-2530 (Pubitemid 39119763)
22. Nowis D, McConnell EJ, Dierlam L, Palamarchuk A, Lass A, Wojcik C. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response. Int J Cancer 2007;121:431-441 (Pubitemid 46917714)
23. Lee AH, Iwakoshi NN, Anderson KC, Glimcher LH. Proteasome inhibitors disrupt the unfolded protein response in myeloma cells. Proc Natl Acad Sci U S A 2003;100:9946-9951 (Pubitemid 37087048)
24. Magi B, Ettorre A, Liberatori S, et al. Selectivity of protein carbonylation in the apoptotic response to oxidative stress associated with photodynamic therapy: a cell biochemical and proteomic investigation. Cell Death Differ 2004;11:842-852 (Pubitemid 39139743)
25. Chen B, Roskams T, Xu Y, Agostinis P, de Witte PA. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model. Int J Cancer 2002;98:284-290 (Pubitemid 34150815)
26. Golab J, Olszewska D, Mroz P, et al. Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy-induced anemia. Clin Cancer Res 2002;8:1265-1270 (Pubitemid 34517667)
27. Golab J, Wilczynski G, Zagozdzon R, et al. Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with GCSF. Br J Cancer 2000;82:1485-1491 (Pubitemid 30175918)
28. Golab J, Kozar K, Kaminski R, et al. Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice. Life Sci 2000;66:1223-1230 (Pubitemid 30112471)
29. Kozar K, Kaminski R, Switaj T, et al. Interleukin 12-based immunotherapy improves the antitumor effectiveness of a low-dose 5-aza-2′-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice. Clin Cancer Res 2003;9:3124-3133 (Pubitemid 36993275)
30. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27-55.
31. Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part three - photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagn Photodyn Ther 2005;2:91-106. (Pubitemid 41160479)
32. Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milzani A. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med 2006;10:389-406.
33. Nystrom T. Role of oxidative carbonylation in protein quality control and senescence. EMBO J 2005;24:1311-1317 (Pubitemid 40593052)
34. Divald A, Powell SR. Proteasome mediates removal of proteins oxidized during myocardial ischemia. Free Radic Biol Med 2006;40:156-164 (Pubitemid 41759413)
35. Pajonk F, Pajonk K, McBride WH. Apoptosis and radiosensitization of Hodgkin cells by proteasome inhibition. Int J Radiat Oncol Biol Phys 2000;47:1025-1032 (Pubitemid 30345603)
36. Ahner A, Brodsky JL. Checkpoints in ER-associated degradation: excuse me, which way to the proteasome? Trends Cell Biol 2004;14:474-478
37. Buytaert E, Callewaert G, Hendrickx N, et al. Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J 2006;20:756-758 (Pubitemid 46671205)
38. 2 in mitochondria of intact cells. J Biol Chem 2003;278:3298-3307
39. Usuda J, Chiu SM, Murphy ES, Lam M, Nieminen AL, Oleinick NL. Domain-dependent photodamage to Bcl-2. A membrane anchorage region is needed to form the target of phthalocyanine photosensitization. J Biol Chem 2003;278:2021-2029 (Pubitemid 36801445)
40. Xue LY, Chiu SM, Oleinick NL. Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Oncogene 2001;20:3420-3427 (Pubitemid 32588990)
41. Salet C, Moreno G, Ricchelli F, Bernardi P. Singlet oxygen produced by photodynamic action causes inactivation of the mitochondrial permeability transition pore. J Biol Chem 1997;272:21938-21943 (Pubitemid 27382813)
42. Buytaert E, Callewaert G, Vandenheede JR, Agostinis P. Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum. Autophagy 2006;2:238-240 (Pubitemid 44030895)
43. Grebenova D, Kuzelova K, Smetana K, et al. Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells. J Photochem Photobiol B 2003;69:71-85. (Pubitemid 36336463)
44. 2+ release initiated by photodamage to the endoplasmic reticulum: scavenging of reactive oxygen species. Cell Death Differ 2005;12:502-511
45. Gomer CJ, Ferrario A, Rucker N, Wong S, Lee AS. Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization. Cancer Res 1991;51:6574-6579
46. Mak NK, Li KM, Leung WN, et al. Involvement of both endoplasmic reticulum and mitochondria in photokilling of nasopharyngeal carcinoma cells by the photosensitizer Zn-BC-AM. Biochem Pharmacol 2004;68:2387-2396 (Pubitemid 39535111)
47. Buytaert E, Matroule JY, Durinck S, et al. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells. Oncogene 2008;27:1916-1929
48. Lin JH, Walter P, Yen TS. Endoplasmic reticulum stress in disease pathogenesis. Annu Rev Pathol 2008;3:399-425.